Trends in prematurity: What do changes at an urban institution suggest about the public health impact of 17-alpha hydroxyprogesterone caproate?

Maternal and Child Health Journal

Volumn 16, Issue 3, 2012, Pages 564-568

  Bastek, Jamie A ^a,b   Adamczak, Joanna E ^a   Hoffman, Stacey ^c   Elovitz, Michal A ^a   Srinivas, Sindhu K ^a  

^a Center for Research on Reproduction and Women's Health   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Late preterm; Preterm birth; Progesterone; Public health

Indexed keywords

17-ALPHA-HYDROXY-PROGESTERONE CAPROATE; GESTAGEN; HYDROXYPROGESTERONE CAPROATE; PROGESTERONE DERIVATIVE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DELIVERY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MALE; NEWBORN; PREGNANCY; PREMATURITY; PUBLIC HEALTH; RECURRENT DISEASE; STATISTICAL MODEL; STATISTICS; URBAN POPULATION;

ADULT; CROSS-SECTIONAL STUDIES; DELIVERY, OBSTETRIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GESTATIONAL AGE; HUMANS; HYDROXYPROGESTERONES; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; LOGISTIC MODELS; MALE; PREGNANCY; PREMATURE BIRTH; PROGESTINS; PUBLIC HEALTH; RECURRENCE; URBAN POPULATION;

EID: 84860887000     PISSN: 10927875     EISSN: 15736628     Source Type: Journal    
DOI: 10.1007/s10995-011-0783-z     Document Type: Article

References (8)

1. Keirse, M. J. (1990). Progestogen administration in pregnancy may prevent preterm delivery. British Journal of Obstetrics and Gynaecology, 97(2), 149-154. (Pubitemid 20134285)
2. Meis, P. J., Klebanoff, M., Thom, E., Dombrowski, M. P., Sibai, B., Moawad, A. H., et al. (2003). National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. New England Journal of Medicine, 348(24), 2379-2385.
3. American College of Obstetricians and Gynecologists. (2008). Use of progesterone to reduce preterm birth. ACOG Committee Opinion No. 419. Obstetrics & Gynecology, 112, 963-965.
4. Hamilton, B. E., Martin, J. A., & Ventura, S. J. (2010). Births: Preliminary data for 2008. National vital statistics reports (Vol. 58, no 16). Hyattsville, MD: National Center for Health Statistics.
5. Moutquin, J. M. (2003). Classification and heterogeneity of preterm birth. British Journal of Obstetrics and Gynaecology, 110(Suppl 20), 30-33.
6. National Center for Health Statistics. (2011). Final natality data. www.marchofdimes.com/peristats. Accessed 22 Feb 2011.
7. American College of Obstetricians and Gynecologists. (2001). Assessment of risk factors for preterm birth. ACOG Practice Bulletin No. 31. Obstetrics & Gynecology, 98, 709-716.
8. Bastek, J. A., Sammel, M. D., Paré, E., Srinivas, S. K., Posencheg, M. A., & Elovitz, M. A. (2008). Adverse neonatal outcomes: examining the risks between preterm, late preterm, and term infants. American Journal of Obstetrics and Gynecology, 199(4), 3671-3678.